SAPA-NE 25th Annual Conference Poised to Pivot: Build Resilience in a Challenging Market

 [Agenda] [Program Book]

Note: Early bird rate ends on Apr 30. All sales are final and NO refund shall be issued. Please reach out to info@sapa-neweb.org if there's any question.

For conference sponsorship opportunity, please email "bd@sapa-neweb.org"

This year Annual Conference comprises a full-day program (9 am – 5 pm) with the following topics:

• Science and Technology Innovation in Drug Discovery
• Drug Development to Deliver Great Impact to People Clinical, Regulatory Affairs, Legal and Global Partnership
• Business Development and Investment in Life Science

Confirmed speakers:

• Jean Zhao, PhD Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School DFCI
• Pat Walters, PhD Chief Data Officer, Relay Therapeutics
• Kevin Tsai, PhD Director Business Development, XtalPi
• Kristen Park Hopson, PhD VP of Preclinical Discovery and Development, Generate Biomedicines
• Mohammadsharif Tabebordbar, PhD Co-founder and CSO of Kate Therapeutics
• Steven Hersch, MD, PhD VP of Clinical Research, Eisai
• Jingsong Wang, MD, PhD CEO of Harbour Biome
• Bu Yin, PhD Associate, Morrison Foerster
• Catherine X. Pan-Giordano Partner, Dorsey & Whitney LLP
• Mark Tabbe, PhD Entrepreneur-in-residence at Atlas Venture
• Michal Preminger, PhD, MBA Regional Head, Johnson & Johnson Innovation, East North America
• Sean Cao, PhD, MBA Managing Director, CBC Capital group